Clinovexa, Clinical Innovation, Evidence and MedTech Development
Clinical Innovation • Evidence • MedTech Development

From clinical need to evidence, regulation and adoption.

Clinovexa supports MedTech and digital health companies across the full product lifecycle, combining medical affairs, clinical research, biostatistics, regulatory evidence, SaMD strategy, medical writing, education and international healthcare development.

MedTech lifecycle Clinical evidence SaMD & digital health International projects
What Clinovexa integrates
Clinical Strategy
CER • SOTA • PMS • PMCF
Protocol • SAP • Statistics
SaMD & Algorithm Evidence
Medical Affairs & Education
Healthcare Systems & Innovation
Lifecycle thinkingFrom intended purpose to post-market evidence
Clinically groundedStrategy shaped by real-world clinical practice
Evidence drivenResearch, statistics and medical writing in one workflow
InternationalMedTech, healthcare systems and strategic partnerships
MedTech Lifecycle & Medical Affairs

End-to-end clinical and evidence support

Clinovexa helps companies connect product development, clinical evidence, regulatory strategy, post-market learning and physician adoption into one coherent development pathway.

01

Clinical & Medical Strategy

Intended purpose, target population, clinical claims, value proposition, clinical development planning, unmet-need analysis, evidence gap assessment and medical affairs strategy.

02

Clinical Research Design

Research questions, study protocols, endpoint strategy, comparator selection, feasibility, observational studies, clinical investigations and multicentre research planning.

03

Biostatistics & SAP

Statistical analysis plans, sample-size strategy, estimands, subgroup and interaction analysis, modelling, interpretation and evidence synthesis.

04

Clinical Evaluation & Medical Writing

Clinical Evaluation Reports, State of the Art reviews, literature evaluation, evidence synthesis, benefit-risk narratives, scientific reports and regulatory medical writing.

05

PMS & PMCF

Post-market surveillance strategy, PMCF planning, PMCF evaluation, safety and performance trending, evidence updates and post-market clinical learning.

06

SaMD & Digital Health

Clinical strategy for software as a medical device, algorithm validation, performance evaluation, clinical evidence planning, human factors and digital health research.

07

Regulatory Development Support

Clinical evidence strategy for EU MDR, evidence-gap remediation, notified-body response support, risk-benefit alignment and integration of clinical, risk and post-market evidence.

08

MedTech Education & Adoption

Advanced physician education, procedural training, clinical implementation, simulation, KOL engagement, advisory boards and technology adoption programmes.

09

Strategic Medical Affairs

Medical leadership, evidence roadmaps, launch preparation, scientific communication, market development, health-economic thinking and clinical partnership strategy.

Innovation & Technology Development

Turning clinical problems into scalable solutions

Clinovexa works at the interface of medicine, technology and research, supporting the development, validation and commercialisation of advanced healthcare solutions.

  • Clinical input into device concept and product design
  • Research and validation strategies for new technologies
  • Cardiovascular and advanced-care innovation
  • Digital health, clinical algorithms and SaMD
  • University and clinical research partnerships
  • Evidence generation for technology adoption and investment
Innovation principle

Start with the clinical problem.

Technology is valuable only when it solves a meaningful clinical problem, generates reliable evidence and can be implemented safely within real healthcare workflows.

International Healthcare Systems

Strategic healthcare and government projects

Clinovexa develops and supports complex healthcare initiatives that combine clinical expertise, technology, education, implementation and system-level design.

Emergency, Trauma & Disaster Healthcare Systems

Integrated programmes for advanced prehospital care, trauma systems, disaster preparedness, civil protection, mass-casualty response, hospital resilience, simulation and emergency technology.

International MedTech & Healthcare Partnerships

Strategic market development, clinical partnerships, technology integration, healthcare consulting, government engagement and cross-border collaboration between healthcare systems and industry.

How We Work

One clinical strategy across the product lifecycle

1Define

Clinical problem, intended purpose, population and claims.

2Design

Evidence plan, protocol, endpoints, statistics and validation.

3Develop

Clinical, regulatory and medical documentation.

4Demonstrate

Safety, performance, clinical benefit and value.

5Deploy

Education, implementation, adoption and post-market learning.

About Clinovexa

Clinical depth. Scientific rigour. Commercial perspective.

Clinovexa is a Swedish health technology and clinical development company focused on MedTech, digital health, evidence generation, medical affairs and international healthcare innovation.

Our Company

Clinovexa supports MedTech and digital health companies across the full product lifecycle, from intended purpose and clinical strategy through research design, biostatistics, CER, SOTA, PMS, PMCF, SaMD evidence, regulatory development, medical writing, education and post-market learning.

The company also develops and supports innovation projects, advanced healthcare technology programmes, and international healthcare-system initiatives in areas including cardiovascular care, trauma, emergency medicine and disaster preparedness.

Dr Mohamed Atwa, Founder and Owner of Clinovexa

Founder & Owner

Dr Mohamed Atwa is the Founder and Owner of Clinovexa.

He is a physician and MedTech clinical leader with extensive experience in cardiac surgery, intensive and peri-operative care, advanced cardiovascular technologies, clinical research, medical affairs and medical-device development.

His work spans the MedTech lifecycle, including clinical strategy, intended use and claims, research protocols, biostatistics and statistical analysis plans, clinical evaluation, State of the Art, PMS, PMCF, SaMD evidence, regulatory clinical development, physician education and international technology implementation.

He also holds postgraduate training in clinical-trial statistics, healthcare quality and healthcare management, with a particular interest in translating clinical problems into evidence-based and commercially scalable healthcare solutions.

View Mohamed Atwa on LinkedIn

Work With Clinovexa

Discuss your next clinical, MedTech or healthcare project.

For consulting, research collaboration, technology development or international healthcare partnerships, contact Clinovexa.